Glycolysis In several tumor cell lines grown in tissue culture was inhibited by methionine. Kfrsten murine sarcoma virus-transformed rat kidney cells (K-NRK) were inhibited 60-75% by 10 mM methionine, whereas normal rat kidney (NRK-49F) cells showed little or no inhibition. Inhibition of glycolysis in K-NRK cells was manifest 2-4 hr after exposure to the amino acid. Glycolysis in a chemically transformed cell line of Madin-Darby canine kidney cells was also sensitive to methionine, but maximal inhibition (75%) required 18-24 hr of incubation with the amino acid. Under the same conditions glycolysis in the nontransformed canine cells was less than 20% inhibited by methionine. In Ehrlich ascites tumor cells grown in tissue culture, 10 mM methionine inhibited glycolysis by about 50%. Inhibition of glycolysis, even by 50 mM methionine, was rapidly reversible. Within 2 hr after removal of methionine the rate of glycolytic activity was restored to that observed in control cells. Furthermore, inhibition by methionine required a minimum level (7%) of serum in the growth medium and inhibition was not sensitive to cycloheximide. Only amino acids that are transported by system A (including the nonmetabolized analogue methylaminoisobutyric acid) specifically inhibited glycolysis in tumor cells. The only exception was phenylalanine, which was toxic to both transformed and normal cell lines.
tion of glycolysis in K-NRK cells was manifest 2-4 hr after exposure to the amino acid. Glycolysis in a chemically transformed cell line of Madin-Darby canine kidney cells was also sensitive to methionine, but maximal inhibition (75%) required [18] [19] [20] [21] [22] [23] [24] hr of incubation with the amino acid. Under the same conditions glycolysis in the nontransformed canine cells was less than 20% inhibited by methionine. In Ehrlich ascites tumor cells grown in tissue culture, 10 mM methionine inhibited glycolysis by about 50%. Inhibition of glycolysis, even by 50 mM methionine, was rapidly reversible. Within 2 hr after removal of methionine the rate of glycolytic activity was restored to that observed in control cells. Furthermore, inhibition by methionine required a minimum level (7%) of serum in the growth medium and inhibition was not sensitive to cycloheximide. Only amino acids that are transported by system A (including the nonmetabolized analogue methylaminoisobutyric acid) specifically inhibited glycolysis in tumor cells. The only exception was phenylalanine, which was toxic to both transformed and normal cell lines.
It has been known for many years that tumors have an altered methionine metabolism (1) (2) (3) (4) (5) . The most striking differences are (i) the inability of many tumor cell lines to grow at low concentrations of methionine or when methionine was replaced by homocysteine, and (ii) a low level of intracellular methionine and S-adenosylmethionine. Yet these same cell lines synthesize methionine and incorporate it into proteins at rates comparable to those in normal cells. Furthermore, most transformed cell lines take up methylaminoisobutyrate (MeAIB), methionine, and other substrates via system A for amino acid transport at a considerably faster rate than their "normal" parent cells (6) (7) (8) . These puzzling and paradoxical observations are unexplained. Preliminary experiments (unpublished data) showed that MeAIB, a specific substrate for system A (9), inhibited the growth of the MDCK-T1 cell line, a chemically transformed variant of Madin-Darby canine kidney (MDCK) cells (10), but did not significantly inhibit the growth of MDCK cells. A similar sensitivity to MeAIB or to methionine was observed with Ehrlich ascites tumor (EAT) cells grown in tissue culture (unpublished data of P.B. and D. Westcott). We also observed that glycolysis of confluent normal rat kidney cells (NRK-49F) was stimulated by transforming growth factor (3 6) and that the stimulation of glycolysis by TGF-,3 was inhibited in the presence of high concentrations of methionine (11) . These observations prompted us to explore the effect of methionine on glycolysis of transformed cells grown in tissue culture and to ask if culture conditions influenced the response of these cells to methionine.
In this paper we describe and further characterize the effect of methionine and other substrates of system A on glycolysis in several transformed and nontransformed cell lines.
MATERIALS AND METHODS
The MDCK cells, adapted for growth on glass, were originally obtained from John Holland (University of California, San Diego). The MDCK-T1 cell line was produced by nitrosoguanidine mutagenesis and selection for tumorigenicity in the adult nude mouse (10) . The EAT cell line grown in tissue culture was obtained from E. C. Henshaw (University of Rochester Medical Center). NRK-49F and NRK cells transformed by Kirsten murine sarcoma virus (K.NRK cells) were obtained from G. Todaro. Other cell lines were obtained as described previously (12) or from the American Type Culture Collection (Rockville, MD). NRK, NRK-49F, K-NRK, baby hamster kidney (BHK), polyoma virus-transformed BHK (Py-BHK), and HeLa (human) cells were grown in Dulbecco's modified Eagle's medium (DME medium) supplemented with 10% calf serum. MDCK and MDCK-T1 cells were maintained in DME medium supplemented with 7.5% horse serum and 2.5% fetal calf serum. Growth of these cells in hormone-supplemented DME/Ham's medium F12 (1:1) has been described (13) . Lactate was measured as described (14) . Briefly, at the times indicated in the legends to the figures, the growth medium was removed, the cells were washed twice with (2-4 days) . At zero time the growth medium was replaced with fresh DME/10%o calf serum containing the indicated concentrations of methionine. After 4.5-5 hr the medium was removed and lactate production was assayed. Control activities in nmol of lactate per min per mg of protein were as follows for NRK49F, NRK, and K-NRK cells: 13.9, 22.2, and 32.9, respectively; for BHK and Py-BHK: 33.2 and and 36.6, respectively.
induced by TGF-j3 (11) . We then examined in greater detail the effect of methionine and other amino acids on glycolysis in established tumor cell lines. The sensitivity ofglycolysis to methionine was examined in NRK49F, NRK, and K-NRK cells. It can be seen in Fig. 1A that glycolysis in K-NRK cells was highly sensitive to methionine. A 25% inhibition was observed at 1 mM and maximal inhibition (ca. 700%) at 5-10 mM. Glycolysis in confluent nontransformed NRK-49F cells showed little sensitivity to methionine, even at a concentration as high as 50 mM. Glycolysis in a line of NRK cells obtained from the American Type Culture Collection, which formed tumors at a low frequency in nude mice (unpublished observations), showed a sensitivity to methionine intermediate between that of NRK49F and K-NRK. Glycolysis was also inhibited 20-25% by 10 mM methionine in subconfluent growing NRK49F or NRK cells, but these cells were clearly less sensitive than K-NRK cells. A similar differential sensitivity to methionine was observed in BHK and Py-BHK cells (Fig. 1B) . MDCK-T1 cells were much more sensitive to inhibition than the nontransformed parent, but a longer time of exposure than with the other transformed cell lines was required for maximal inhibition (Fig. 2) . HeLa cells also required a long time of exposure to methionine before maximal inhibition (75%) was observed (data not shown).
A comparison of the effect of various amino acids on glycolysis revealed that substrates of system A, including MeAIB, a nonmetabolized synthetic substrate for this transporter, were all effective inhibitors ( Table 1 ). The only exception was phenylalanine, which inhibited glycolysis in both transformed and untransformed cells. But on microscopic examination phenylalanine was observed to be toxic to cells incubated in the salts/glucose medium used to measure glycolysis. The most effective and consistent inhibition of glycolysis in both EAT and K-NRK cells was observed with methionine; the effects of MeAIB and of other substrates of system A were less pronounced and more variable.
Time Course and Reversal of Methionine Inhibition. As shown in Fig. 3 , inhibition of glycolysis in EAT cells was maximal by 2.5 hr but was readily reversed after removal of methionine. Recovery began within 0.5 hr after replacement of the methionine-containing medium with fresh medium and was complete by 1.5-2 hr. The increase in the glycolytic rate in the control cells seen in Fig. 3 was due to the introduction of fresh medium at the beginning of the experiment. The inhibition ofglycolysis by methionine in K-NRK cells and the reversal of inhibition in EAT cells was not eliminated by cycloheximide (Fig. 4) . The significant inhibition of glycolysis by cycloheximide in the absence of methionine remains to be explained. A similar inhibition of glycolysis by cyclohex-100. .xio paeat1xlscells per 35-mm dish inDME/10%o calf serum. After 2dy h 2 astegrowth medium was replaced with fresh medium containin-5m ing 50 mM methionine. After 5 hr the cells were washed twice with DME medium and fresh medium or fresh medium containing 50 mM methionine was added. Cycloheximide (25 ,ug/ml) was present as indicated. After 1.5 hr lactate production was assayed for 30 min in the presence or absence of methionine and cycloheximide as indicated.
required the presence of at least 7% serum in the medium (Fig. 5) .
We do not know the mechanism by which methionine inhibits glycolysis, but in view of the observations recorded below it seems unlikely that one of the glycolytic enzymes is After 1 day the growth medium was removed, the cells were washed with DME medium, and fresh DME medium containing calf serum at the indicated concentrations was added. After 1 day 10 mM methionine was added to the medium for 4.5 hr and lactate production was assayed. The control rates of lactate production by NRK-49F cells grown in medium containing 0.1% and 10% calf serum were, respectively, 10.1 and 18. We have shown previously that the stimulation of glycolysis by TGF-f3 is inhibited by cycloheximide (11) . Since in the absence of TGF-f3 there was no inhibition by methionine, it was not possible to decide whether inhibition by methionine was also sensitive to cycloheximide. It was clearly shown in this paper that in transformed cells inhibition by methionine is still observed in the presence of cycloheximide.
In view of the observations that tumor cells have a low intracellular methionine content (4, 5) , it is tempting to propose that the high aerobic glycolysis in tumors may be related to this phenomenon. The fact that amino acid transport via system A is actually accelerated in transformed cells (6) (7) (8) is obviously inconsistent with the observations of a low intracellular concentration of methionine and suggests that there is either accelerated utilization or excretion of methionine. In any case, the question of why high concentrations of methionine inhibit glycolysis needs to be answered.
Although we are on highly speculative grounds, we propose that methionine transport by system A, which is known to be linked to a sodium gradient, may also be driven by ATP. There are some indications to support this (20) . A particularly attractive model would be the operation of a "moped" (21) , an auxiliary but optional ATP-driven pump of amino acids, which would explain why in vesicles and reconstituted systems no evidence for an ATP requirement has emerged (22) (23) (24) . It may be necessary to isolate vesicles in the presence of protease inhibitors similar to those that protected the Na+/H' moped of Streptococcus faecalis from losing its motor (21) .
We stress the significance of the data shown in Fig. 6 . It is apparent that NP-40 stimulates glycolysis severalfold and that the stimulated rate is not sensitive to methionine. This strongly suggests that (i) ATP hydrolysis is a rate-limiting factor for glycolysis, since the latter is enhanced by activation of the mitochondrial ATPase, and (it) methionine does not inhibit glycolysis that is driven by the mitochondrial or the Na+,K+-ATPase.
Finally, we would like to mention that in vivo experiments (unpublished) indicated that high concentrations of methionine in the food and drinking water of mice clearly retarded the growth of EAT cells, which, however, resumed when the high-methionine diet was replaced by regular Purina pellets. Inhibition of tumor growth by methionine has been previously observed (25) . This investigation was supported by Grant CA-08964 awarded by the National Cancer Institute.
